ZA859881B - Pharmaceutically active compound and a method for its preparation - Google Patents

Pharmaceutically active compound and a method for its preparation

Info

Publication number
ZA859881B
ZA859881B ZA859881A ZA859881A ZA859881B ZA 859881 B ZA859881 B ZA 859881B ZA 859881 A ZA859881 A ZA 859881A ZA 859881 A ZA859881 A ZA 859881A ZA 859881 B ZA859881 B ZA 859881B
Authority
ZA
South Africa
Prior art keywords
preparation
active compound
pharmaceutically active
pharmaceutically
compound
Prior art date
Application number
ZA859881A
Other languages
English (en)
Inventor
Boerje Rosen
Kurt Leander
Original Assignee
Conpharm Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Conpharm Ab filed Critical Conpharm Ab
Publication of ZA859881B publication Critical patent/ZA859881B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA859881A 1984-12-28 1985-12-30 Pharmaceutically active compound and a method for its preparation ZA859881B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8406660 1984-12-28

Publications (1)

Publication Number Publication Date
ZA859881B true ZA859881B (en) 1986-09-24

Family

ID=20358339

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA859881A ZA859881B (en) 1984-12-28 1985-12-30 Pharmaceutically active compound and a method for its preparation

Country Status (23)

Country Link
US (1) US4788216A (xx)
EP (1) EP0207124B1 (xx)
JP (2) JPH0720966B2 (xx)
CN (1) CN1006795B (xx)
AP (1) AP32A (xx)
AT (1) ATE68186T1 (xx)
AU (1) AU585936B2 (xx)
CA (1) CA1255230A (xx)
DE (1) DE3584370D1 (xx)
DK (1) DK169506B1 (xx)
DZ (1) DZ876A1 (xx)
EG (1) EG17788A (xx)
ES (1) ES8701761A1 (xx)
FI (1) FI89330C (xx)
GR (1) GR853145B (xx)
HU (1) HU201672B (xx)
IL (1) IL77456A (xx)
MA (1) MA20602A1 (xx)
NO (1) NO863329D0 (xx)
PT (1) PT81760B (xx)
TN (1) TNSN86004A1 (xx)
WO (1) WO1986004062A1 (xx)
ZA (1) ZA859881B (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4644072A (en) * 1985-04-12 1987-02-17 Bristol-Myers Company Intermediates for the production of epipodophyllotoxin and related compounds and processes for the preparation and use thereof
DE69033342T2 (de) * 1989-02-23 2000-05-11 University Of North Carolina At Chapel Hill, Chapel Hill Etoposidanaloge
SE464167B (sv) 1989-07-31 1991-03-18 Analytecon Sa Topisk farmaceutisk beredning av podophyllotoxin
US5332811A (en) * 1989-09-12 1994-07-26 The University Of North Carolina At Chapel Hill Etopside analogs
US5338867A (en) * 1992-04-24 1994-08-16 Genelabs Technologies, Inc. Preparation of 4β- amino podophyllotoxin compounds
SE9301831D0 (sv) * 1993-05-28 1993-05-28 Analytecon S A Pharmaceutical compositions
GB9422947D0 (en) * 1994-11-14 1995-01-04 Univ Salamanca Immunosuppressive cyclolignan derivatives
US6051721A (en) * 1997-10-02 2000-04-18 The Board Of Regents Of The University Of Nebraska Ring E-modified analogues of(-)-podophyllotoxin and etoposide and a method for their synthesis
FI105152B (fi) 1998-07-17 2000-06-30 Eero Saarela Paikallinen kivunlievitysmenetelmä
US6143304A (en) * 1999-08-17 2000-11-07 The University Of Mississippi Enhanced yield of podophyllotoxin from natural products through in situ conversion methods
KR20040030686A (ko) * 2001-06-19 2004-04-09 악셀라르 아베 시클로리그난의 신규의 용도 및 신규의 시클로리그난
SE0102168D0 (sv) 2001-06-19 2001-06-19 Karolinska Innovations Ab New use and new compounds
SE0203746D0 (sv) * 2002-12-18 2002-12-18 Karolinska Innovations Ab New compounds
US20110178050A1 (en) * 2008-06-23 2011-07-21 Axelar Ab Use of cyclolignans for the treatment of a hyperactive immune system
EP2817007A1 (en) * 2012-02-24 2014-12-31 Nestec S.A. Peltatin for the treatment of chronic inflammatory disorders
WO2015028456A1 (en) * 2013-08-28 2015-03-05 Nestec S.A. PPAR modulators
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA635769A (en) * 1962-01-30 Rutschmann Jurg Amides of podophyllic acid and picropodophyllic acid
SE335139B (xx) * 1964-08-12 1971-05-17 Sandoz Ag
US4122092A (en) * 1977-08-25 1978-10-24 University Of Rochester Total synthesis of (±)-picropodophyllone and (±)-4'-demethylpicropodophyllone
US4567253A (en) * 1984-02-03 1986-01-28 Tony Durst 2-Substituted derivatives of podophyllotoxin and etoposide
GB8424269D0 (en) * 1984-09-26 1984-10-31 Pharma Medica As Isolation and purification of podophyllotoxin

Also Published As

Publication number Publication date
FI89330C (fi) 1993-09-27
AU5300386A (en) 1986-07-29
EP0207124B1 (en) 1991-10-09
AP8500017A0 (en) 1985-11-01
NO863329L (no) 1986-08-19
ATE68186T1 (de) 1991-10-15
DK408186D0 (da) 1986-08-27
ES8701761A1 (es) 1986-12-01
HU201672B (en) 1990-12-28
FI863482A (fi) 1986-08-27
CN1006795B (zh) 1990-02-14
JPH0720966B2 (ja) 1995-03-08
AP32A (en) 1988-12-07
GR853145B (xx) 1986-04-29
DE3584370D1 (de) 1991-11-14
CN85109666A (zh) 1986-10-29
WO1986004062A1 (en) 1986-07-17
PT81760B (pt) 1987-11-11
HUT47582A (en) 1989-03-28
IL77456A (en) 1989-07-31
US4788216A (en) 1988-11-29
DK169506B1 (da) 1994-11-14
FI863482A0 (fi) 1986-08-27
AU585936B2 (en) 1989-06-29
MA20602A1 (fr) 1986-07-01
DK408186A (da) 1986-08-27
EG17788A (en) 1990-12-30
JPS62501360A (ja) 1987-06-04
FI89330B (fi) 1993-06-15
TNSN86004A1 (fr) 1990-01-01
DZ876A1 (fr) 2004-09-13
NO863329D0 (no) 1986-08-19
CA1255230A (en) 1989-06-06
IL77456A0 (en) 1986-08-31
JPH07173063A (ja) 1995-07-11
JP2572558B2 (ja) 1997-01-16
ES550504A0 (es) 1986-12-01
PT81760A (en) 1986-01-02
EP0207124A1 (en) 1987-01-07

Similar Documents

Publication Publication Date Title
ZA899794B (en) New therapeutically active compound and a process for its preparation
GB2163648B (en) Pharmaceutical preparation and a method of making the same
AU573369B2 (en) A rumen injector
GR861484B (en) Method for the preparation of active compounds
GB2146989B (en) Pharmaceutically active hydroxypyridones
EG17788A (en) Pharmaceutically active compound and a method for its preparation
PT86000A (en) Pharmaceutically active compounds
AU6644986A (en) S-(-)-1-propyl-2', 6' pipecoloxylidide hydrochloride monohydrate and a method for its preparation
GB2159836B (en) Copper-nickel-tin-titanium-alloy and a method for its manufacture
ZA897677B (en) Method for the preparation of a biologically active substance
ZA885992B (en) High potency biomass-free avoparcin and a method for its preparation
PH21558A (en) Organochemical compound
PT78440A (en) Preparation of a pharmaceutically active pyridazine derivative
ZA875174B (en) A method for the preparation of a therapeutically active compound
EP0106335A3 (en) Pharmaceutical composition and a method for enhancing the absorption of a pharmaceutically active compound
IL71589A0 (en) Preparation of a pharmaceutically active pyridazine derivative
GB8419252D0 (en) Pharmaceutically active compounds
BG48273A1 (en) Polymerisationable oligoimide and method for its preparation
BG47569A1 (en) 1- thiocarbamoylmethylpyrolidene- 2- tion and method for its preparation
IE842735L (en) Pharmaceutically active ketones
GB8625739D0 (en) Pharmaceutically active compounds
GR3020329T3 (en) Pharmaceutically active compounds
GB8416650D0 (en) Active compound
GB8332461D0 (en) Pharmaceutically active compounds
GB8328415D0 (en) Pharmaceutically active compounds